ABIO News and Press, ARCA biopharma Inc. From 04/04/24

2024-04-04 10:00:16 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli ...

2024-04-04 08:25:40 ET More on Pre-market losers & stocks. Borr Drilling: Downgrading On Potential Saudi Aramco Jackup Market Impact Borr Drilling: Fundamentals Remain Strong Ecopetrol Pays Out 18% Yield With Successful Permian Play And Gas Exploration Am...

A look at the top 10 most actives in the United States Kintara Therapeutics Inc. (KTRA) rose 63.3% to $0.164 on volume of 223,092,889 shares C3is Inc. (CISS) rose 24.2% to $0.0508 on volume of 148,576,579 shares Nikola Corporation (NKLA) fell 8.4% to $0.8918 on volume of 128,870,418 share...

2024-04-03 11:38:38 ET Arca Biopharma Inc (NASDAQ: ABIO) more than doubled on Wednesday after announcing a merger agreement with Oruka Therapeutics. Oruka CEO comments on Arca Biopharma stock deal The combined company following completion of the all-stock transaction will operat...

ARCA Biopharma, Inc. (NASDAQ: ABIO) is one today's most active stocks by volume. So far today, approximately 46.54M shares of ARCA Biopharma, Inc. have been exchanged, as compared to an average 30-day volume of 26,286 shares. ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, de...

2024-04-03 10:00:34 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Eli ...

A look at the top 10 most actives in the United States Kintara Therapeutics Inc. (KTRA) rose 99.9% to $0.2007 on volume of 121,318,217 shares Next.e.GO N.V. (EGOX) rose 30.8% to $0.034 on volume of 63,981,361 shares C3is Inc. (CISS) rose 20.8% to $0.0494 on volume of 63,446,681 shares I...

2024-04-03 07:51:20 ET More on ARCA biopharma Financial information for ARCA biopharma Read the full article on Seeking Alpha For further details see: ARCA biopharma to merge with Oruka Therapeutics in all-stock transaction

Merger to create a company focused on advancing Oruka’s portfolio of novel biologics that aim to redefine the standard of care for patients with chronic skin diseases Oruka, the third company founded based on assets generated by Paragon Therapeutics, expects to advance ORKA-001 and...

ARCA biopharma Inc. (ABIO) is expected to report for Q4 2023